Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-01-04

Clinical Trial Update: Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for oral squamous cell carcinoma was terminated. Results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • CISPLATIN (cisplatin)
  • DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Emory University | Conditions: Squamous Cell Carcinoma, Oral Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-01-04